Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program.
Chirayu GoswamiMichael SheldonChristian BixbyMehdi KeddacheAlexander BogdanowiczYihe WangJonathan SchultzJessica McDevittJames LaPortaElaine KwonSteven BuyskeDana GarbolinoGlenys BiloholowskiAlex PastuszakMary StorellaAmit BhallaFlorence Charlier-RodriguezRuss HagerRobin GrimwoodShareef A NahasPublished in: BMC infectious diseases (2022)
These initial analyses highlight the importance of sequencing platform, sample collection methods, and RT-PCR Ct values in guiding surveillance efforts. These surveillance studies evaluating genetic changes of SARS-CoV-2 have been identified as critical by the CDC that can affect many aspects of public health including transmission, disease severity, diagnostics, therapeutics, and vaccines.